Most Recent Papers
-
Treatment of Prescription Drug Abuse with Successful Endea ...
Author: Robert DuPont MD, Willia ...
22nd-May-2013 | Page Views: 644Successful Endeavors and Outcomes in the treatment of Prescription Drug Abuse - This pdf is about to Analyze the latest data about the cost of prescription drug abuse to hospitals. Explain the Physician Health Program model’s relevance to the treatm ... -
Pharmaceutical Take-Back and DEA Regulations
Author: Scott Cassel
21st-May-2013 | Page Views: 700Pharmaceutical Take-Back and DEA Regulations - National Rx Drug Abuse Summit. Pharmaceu)cal Take Back and the Proposed DEA Regulations. Scott Cassel, CEO and Founder The Product Stewardship Institute. Scott Cassel has no financial relationships with ... -
PAIN MANAGEMENT STRATEGY: stepped care model
Author: robertkerns
13th-May-2013 | Page Views: 738VHA NATIONAL PAIN MANAGEMENT STRATEGY Implementation of a stepped care model of pain management. This PDF is about to Tell an overview of Pain Management Task Force. Outline similarities and differences with pain management challenges facing Departme ... -
Prescription Drug Abuse: Legistative and Policy Initiative ...
Author: NAMSDL
9th-May-2013 | Page Views: 920This project was supported in part by Cooperative Agreement No. 2012-DC-BX-K002 awarded by the Bureau of Justice Assistance. The Bureau of Justice Assistance is a component of the Office of Justice Programs, which also includes the Bureau of Justice ... -
Pain Management Treatment Options
Author: Richard P. Petri Jr
8th-May-2013 | Page Views: 2056Military Workshop Beyond Medications: Military Medicine’s Expansion of Pain Management Treatment Options. The cycle of herbals and NCCAM Classification of CAM Therapies. What is the usage of CAM in the Military? Unique Aspects of Military and IM as w ... -
Treating Pain and dealing with Drug Overdose
Author: Randy Easterling MD, Dan ...
3rd-May-2013 | Page Views: 681Treating Pain and dealing with Drug Overdose - Disclosure Statement Randy Easterling has no financial rela%onships with proprietary en%%es that produce health care goods and services. Daniel BarneD has no financial rela%onships with proprietary en%%e ...
Premium News Release
NewsFeed
Avion unveils Prenate Chewable prenatal vitamin - Pharmaceutical Business Review
Avion Pharmaceuticals has unveiled a chewable, chocolate-flavored version of the Prenate prenatal vitamin family, Prenate C...
Valeant inaugurates international headquarters in Laval - Pharmaceutical Business Review
Valeant chairman and CEO Michael Pearson said the company had a strong Canadian presence always and expect to conti...
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) drug Linzess might not be ... - GSPInsider
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) closed its day at $13.49. The introductory price for the day was $13.41...
Impax Hires Specialists to Help Sort Manufacturing Issues - In-PharmaTechnologist.com
In-PharmaTechnologist.com Faced with manufacturing quality questions that caused the FDA to reject its poten...
Bioartificial Liver Project Looks to Disposable Bioreactors for Large Scale ... - In-PharmaTechnologist.com
In-PharmaTechnologist.com Disposable bioreactors could be the centerpiece of a project to develop...
ACADIA Pharmaceuticals Inc (NASDAQ:ACAD) targets on small molecule drugs ... - GSPInsider
MarketWatch (press release) ACADIA Pharmaceuticals Inc (NASDAQ:ACAD): In Tuesday's trading session, ACADIA Phar...
White Papers
-
The 450mm Semiconductor Wafer Size Transition contrasted to Prior Generations
We all know why some want to make the leap to 450mm wafers. Larger wafers have always brought benefits in terms of an areal gain that is about 2-2.5x, a cost-per-transistor benefit that is roughly equ ...
-
Analytic Strategies: Samsung
Current Strategy and Tactics, Samsung's Customer Satisfaction, Samsung's business leverage point, Samsung's External Sales Mirror Internal, Market Share, Samsung's Largest Customers, If it's electroni ...
-
Frontiers of Characterization and Metrology for Nanoelectronics
The biggest takeaway: The huge progress that's been made over the last two years in moving exotic technologies towards production versus prior conference nodes where progress was more evolutionary and ...
